Evidence map›Paper›PMID 33446486›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

On the utility of CSF1R inhibitors.

Kim N Green, David A Hume

Abstract readLetterComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Reply to Green and Hume: Nonmicroglia peripheral immune effects of short-term CSF1R inhibition with PLX5622.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Review
  18. Glial Cells Promote Myelin Formation and Elimination.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kim N GreenDepartment of Neurobiology and Behavior, University of California, Irvine, CA 92697; kngreen@uci.edu david.hume@uq.edu.au.
David A HumeMater Research Institute, University of Queensland, Woolloongabba, Qld 4102, Australia kngreen@uci.edu david.hume@uq.edu.au.ORCID https://orcid.org/0000-0002-2615-1478

Funding

Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brainR01NS083801 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Kim Green · 2014 to 2026
$5.6M
Microglia are necessary for cortical plaque formation in Alzheimer's diseaseRF1AG056768 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI GREEN, KIM · 2018 to 2018
$2.7M
NIA NIH HHS RF1 AG056768NINDS NIH HHS R01 NS083801
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Receptor Protein-Tyrosine KinasesReceptors, Colony-Stimulating FactorHematopoiesisMacrophagesReceptor Protein-Tyrosine KinasesReceptors, Colony-Stimulating Factor

Identifiers

PMID33446486
PMCPMC7848745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.